✦ LIBER ✦

Calpain regulates sensitivity to trastuzumab and survival in HER2-positive breast cancer

✍ Scribed by Kulkarni, S; Reddy, K B; Esteva, F J; Moore, H C F; Budd, G T; Tubbs, R R

Book ID: 109971201
Publisher: Nature Publishing Group
Year: 2009
Tongue: English
Weight: 751 KB
Volume: 29
Category: Article
ISSN: 0950-9232
DOI: 10.1038/onc.2009.422

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

306: Chemotherapy sensitizes p95HER2-pos

306: Chemotherapy sensitizes p95HER2-positive breast cancers to trastuzumab

✍ Morancho, B.; Parra-Palau, J.L.; Peg, V.; Vicario, R.; Zacarias-Fluck, M.; Peder 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Adjuvant Trastuzumab in HER2-Positive Br

Adjuvant Trastuzumab in HER2-Positive Breast Cancer

✍ Slamon, Dennis; Eiermann, Wolfgang; Robert, Nicholas; Pienkowski, Tadeusz; Marti 📂 Article 📅 2011 🏛 Massachusetts Medical Society 🌐 English ⚖ 713 KB

Trastuzumab cost effective in HER2-posit

Trastuzumab cost effective in HER2-positive breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 125 KB

Trastuzumab cost effective in HER2-posit

Trastuzumab cost effective in HER2-positive breast cancer

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 126 KB

HER2-Positive Breast Cancer: From Trastu

HER2-Positive Breast Cancer: From Trastuzumab to Innovatory Anti-HER2 Strategies

✍ Nicolas Whenham; Véronique D'Hondt; Martine J. Piccart 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 352 KB

Paclitaxel, carboplatin, and trastuzumab

Paclitaxel, carboplatin, and trastuzumab in HER2-positive metastatic breast cancer

✍ Andrew D. Seidman; Larry Norton 📂 Article 📅 2005 🏛 Current Science Inc. 🌐 English ⚖ 136 KB